Human Papilloma Virus (HPV) is an extremely common virus that causes cancer in all genders. Head and neck (oropharyngeal) cancers caused by HPV have increased by 225% in the last 20 years, primarily in men in their 50s and 60s. These cancers were estimated to surpass cervical cancers by the year 2020, but in Massachusetts, they already have. Thankfully, there is a vaccine that prevents almost all strains of oncogenic HPV, but the dental team has only been recently utilized to help in HPV cancer prevention. This course will educate attendees on the pathophysiology of HPV-related lesions, screening for oropharyngeal cancer, educating staff and patients, and reducing HPV through vaccine referral. A primary focus of the course will be on patient-provider communication. This is a crucial public health issue for the whole dental team; we can go a long way in early diagnosis and prevention of oropharyngeal cancer.